Imaging in Drug Development
Jeffrey L. Evelhoch, Ph.D., and John R. Griffiths, M.B.B.S., D.Phil., Organizers

Monday, 14 July, 10:30 - 12:30
Last updated 05 May 2009

Course Description:
This two-hour course will provide an introduction to how radiologists can become involved in the emerging role of MR in drug-development.  Examples of applications in the development of drugs for a variety of diseases will be reviewed.

Educational Objectives:
Upon completion of this session, participants should be able to:

 Identify the key objectives of an MR study in development of a given drug;
Explain why MR methodology studies (e.g., reproducibility, validation) should precede deployment of MR in clinical trials of novel therapy;
Recommend MR protocols for use in drug development; explain how and why these differ from protocols used in routine diagnostic practice;
Recognize the impact of Good Clinical Practice regulations in the MR study, and advise physicist and physician co-workers accordingly.

Monday, 14 July

David S. Lester and Steve C.R. Williams, Moderators
10:30 The Emerging Role of MR in Drug Development John C. Waterton
10:50 Imaging and Neurological Drug Development Douglas L. Arnold
11:10 Imaging and Cardiovascular Drug Development Chun Yuan
11:30 Imaging and Oncologic Drug Development Teresa McShane
11:50 Imaging and Arthritis Drug Development Charles G. Peterfy
12:10 What Radiologists Need to Know About Roles and Rules in Clinical MR Trials Richard P. Jacobs
12:30 Adjournment